447 related articles for article (PubMed ID: 21550819)
21. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
Lidsky ME; Markovic JN; Miller MJ; Shortell CK
J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
[TBL] [Abstract][Full Text] [Related]
23. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
Khandpur S; Sharma VK
Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
[TBL] [Abstract][Full Text] [Related]
24. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous intra-operative sclerotherapy and surgical resection of cervicofacial venous malformations.
MacArthur CJ; Nesbit G
Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():143-146. PubMed ID: 30634101
[TBL] [Abstract][Full Text] [Related]
26. Sclerotherapy of craniofacial venous malformations: complications and results.
Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
[TBL] [Abstract][Full Text] [Related]
27. Sclerotherapy to a large cervicofacial vascular malformation: a case report with 24 years' follow-up.
Yildirim I; Cinar C; Aydin Y; Cayci C
Head Neck; 2005 Jul; 27(7):639-43. PubMed ID: 15880394
[TBL] [Abstract][Full Text] [Related]
28. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.
Lee BB; Do YS; Byun HS; Choo IW; Kim DI; Huh SH
J Vasc Surg; 2003 Mar; 37(3):533-8. PubMed ID: 12618688
[TBL] [Abstract][Full Text] [Related]
29. [Interdisciplinary concept for classification and treatment of vascular anomalies in the head and neck].
Ernemann U; Hoffmann J; Breuninger H; Reinert S; Skalej M
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):402-9. PubMed ID: 12447652
[TBL] [Abstract][Full Text] [Related]
30. Masseteric venous malformations: diagnosis, treatment, and outcomes.
Rosbe KW; Hess CP; Dowd CF; Frieden IJ
Otolaryngol Head Neck Surg; 2010 Dec; 143(6):779-83. PubMed ID: 21109077
[TBL] [Abstract][Full Text] [Related]
31. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of sclerotherapy and embolization for arteriovenous and venous malformations.
Bowman J; Johnson J; McKusick M; Gloviczki P; Driscoll D
Semin Vasc Surg; 2013 Mar; 26(1):48-54. PubMed ID: 23932562
[TBL] [Abstract][Full Text] [Related]
33. Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.
Stimpson P; Hewitt R; Barnacle A; Roebuck DJ; Hartley B
Int J Pediatr Otorhinolaryngol; 2012 Apr; 76(4):569-73. PubMed ID: 22341629
[TBL] [Abstract][Full Text] [Related]
34. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
[TBL] [Abstract][Full Text] [Related]
35. Preoperative Embolization of Venous Malformations Using n-Butyl Cyanoacrylate.
Uller W; El-Sobky S; Alomari AI; Fishman SJ; Spencer SA; Taghinia AH; Chaudry G
Vasc Endovascular Surg; 2018 May; 52(4):269-274. PubMed ID: 29544400
[TBL] [Abstract][Full Text] [Related]
36. New approaches to the treatment of congenital vascular malformations (CVMs)--a single centre experience.
Lee BB
Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):184-97. PubMed ID: 15949959
[TBL] [Abstract][Full Text] [Related]
37. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
Kishi K; Morita N; Terada T; Sato M
Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
[TBL] [Abstract][Full Text] [Related]
38. Outcomes and complications of sclerotherapy for venous malformations.
Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
[TBL] [Abstract][Full Text] [Related]
39. Preliminary experience with intraoperative near-infrared fluorescence imaging in percutaneous sclerotherapy of soft-tissue venous malformations.
Ishikawa K; Sasaki S; Furukawa H; Nagao M; Iwasaki D; Saito N; Yamamoto Y
Dermatol Surg; 2013 Jun; 39(6):907-12. PubMed ID: 23433041
[TBL] [Abstract][Full Text] [Related]
40. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
